Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Erlotinib can cause unexpected side effects like eyelash growth and scarring.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Tofacitinib may help treat severe hair loss, but more research is needed.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Baricitinib may effectively treat oral lichen planus.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

A new compound shows promise as a topical treatment for hair loss.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Ruxolitinib can help regrow hair in severe alopecia areata.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.